The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
The non-competitive N-methyl-D-aspartate receptor/channel antagonist dizocilipine maleate (MK-801) has been reported to reduce infarct volume in a variety of focal stroke models. We examined the effect of MK-801 on infarct volume and cerebral blood flow in temporary and permanent focal ischemia in r...
Main Authors: | Buchan, A, Slivka, A, Xue, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1992
|
Similar Items
-
MK-801 REDUCES THE VOLUME OF NEOCORTICAL INFARCTION BUT ALSO INCREASES REGIONAL CEREBRAL BLOOD-FLOW
by: Buchan, A, et al.
Published: (1990) -
PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
by: Iversen, S, et al.
Published: (1987) -
HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
by: Buchan, A, et al.
Published: (1992) -
The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
by: Tricklebank, MD, et al.
Published: (1989) -
Protective effect of resveratrol on kidney and liver histopathology induced by nmda receptor antagonist mk-801 in mice
by: Murat Sırrı AKOSMAN, et al.
Published: (2019-08-01)